• 1
    Smith MA, Gurney JG, Ries LAG. Cancer among adolescents 15–19 years old. In Ries LAG, Smith MA, Gurney JG et al, eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. NIH publication no. 99-4649. Bethesda, MD: National Institutes of Health, 1999:157164.
  • 2
    Averbook BJ, Lee SJ, Delman KA et al. Pediatric melanoma: analysis of an international registry. Cancer 2013;119:40124019.
  • 3
    Neier M, Pappo A, Navid F. Management of melanomas in children and young adults. J Pediatr Hematol Oncol 2012;34(Suppl 2):S51S54.
  • 4
    Livestro DP, Kaine EM, Michaelson JS et al. Melanoma in the young: differences and similarities with adult melanoma. Cancer 2007;110:614624.
  • 5
    Hill SJ, Delman KA. Pediatric melanomas and the atypical Spitzoid melanocytic neoplasms. Am J Surg 2012;203:61767.
  • 6
    Paradela S, Fonseca E, Prieto VG. Melanoma in children. Arch Pathol Lab Med 2011;135:307316.
  • 7
    Reed D, Kudchadkar R, Zager JS et al. Controversies in the evaluation and management of atypical melanocytic proliferations in children, adolescents, and young adults. J Natl Compr Canc Netw 2013;11:679686.
  • 8
    Spatz A, Ruiter D, Hardmeier T et al. Melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathological aspects. Int J Cancer 1996;68:317324.
  • 9
    van Dijk MC, Aben KK, van Hees F et al. Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions. Histopathology 2008;52:139146.
  • 10
    Vergier B, Prochazkova-Carlotti M, de la Fouchardiere A et al. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. Mod Pathol 2011;24:613623.
  • 11
    Gerami P, Zembowicz A. Update on fluorescence in situ hybridization. Arch Pathol Lab Med 2011;135:830837.
  • 12
    Gerami P, Jewell SS, Morrison LE et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol 2009;33:11461156.
  • 13
    Gerami P, Scolyer RA, Xu X et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol 2013;37:676684.
  • 14
    Bastian BC, Wesselmann U, Pinkel D et al. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 1999;113:10651069.
  • 15
    Berk DR, LaBuz E, Dadras SS et al. Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults—the Stanford experience 1995–2008. Pediatr Dermatol 2010;27:244254.
  • 16
    Raskin L, Ludgate M, Iyer RK et al. Copy number variations and clinical outcome in atypical Spitz tumors. Am J Surg Pathol 2011;35:243252.
  • 17
    Gerami P, Jewell SS, Pouryazdanparast P et al. Copy number gains in 11q13 and 8q34 are highly linked to prognosis in cutaneous malignant melanoma. J Mol Diagn 2011;13:352358.
  • 18
    Gerami P, Mafee M, Lurtsbarapa T et al. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes. Arch Dermatol 2010;146:273278.
  • 19
    Gammon B, Beilfuss B, Guitart J et al. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe. Am J Surg Pathol 2012;36:8188.
  • 20
    Cooper C, Sorrell J, Gerami P. Update in molecular diagnostics in melanocytic neoplasms. Adv Anat Pathol 2012;19:410416.
  • 21
    Gammon B, Gerami P. Fluorescence in situ hybridization for ambiguous melanocytic tumors. Histol Histopathol 2012;27:15391542.
  • 22
    Gerami P, Li G, Pouryazdanparast P et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol 2012;36:808817.
  • 23
    Yazdan P, Cooper C, Sholl LM et al. Homozygous 9p21 deletions for clinical outcomes, histomorphology, BRAF mutation, and p16 expression. Am J Surg Pathol 2014;38:638645.
  • 24
    Senetta R, Paglierani M, Massi D. Fluorescence in-situ hybridization analysis for melanoma diagnosis. Histopathology 2012;60:706714.
  • 25
    Chandler WM, Rowe LR, Florell SR et al. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements. Arch Pathol Lab Med 2012;136:947955.
  • 26
    Zembowicz A, Yang S, Kafanas A et al. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions. Arch Pathol Lab Med 2012;136:15711579.